DIANNA GALVAN: Open Payments
NPI 1497038673 · HARLINGEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$346 in 13 payments from 7 companies in 2025. Trend: 2023 $356 · 2024 $320 · 2025 $346
Food & beverage: $346
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $145 |
| Novartis Pharmaceuticals Corporation | 4 | $70 |
| E.R. Squibb & Sons, L.L.C. | 1 | $36 |
| Amgen Inc. | 2 | $32 |
| Medtronic, Inc. | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $15 |
Products named: LOKELMA, LEQVIO, CAMZYOS, REPATHA, FARXIGA, AZURE XT DR MRI SURESCAN, Kerendia, LifeVest.
Industry payments across TX — which companies pay providers there.
